Temporal nucleotide changes in pertactin and pertussis toxin genes in Bordetella pertussis strains isolated from clinical cases in Poland

被引:61
作者
Gzyl, A
Augustynowicz, E
van Loo, I
Slusarczyk, J
机构
[1] Natl Inst Hyg, Dept Sera & Vaccines Evaluat, PL-00791 Warsaw, Poland
[2] Natl Inst Publ Hlth & Environm, Res Lab Infect Dis, NL-3720 BA Bilthoven, Netherlands
关键词
Bordetella pertussis; pertactin; pertussis toxin;
D O I
10.1016/S0264-410X(01)00356-5
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Growing number of Bordetella pertussis infections in 1997-1998 in Poland overshadowed the successful national vaccination program. This situation prompted us to investigate if this shift reflects changes in the B. pertussis population. We investigated the possible divergence in genes encoding pertussis toxin subunit I (PtxS1) and pertactin (P.69) in B. pertussis population strains during the period of 1960-2000. The pertussis toxin and pertactin variants (ptxS1B and prn1)were found in strains used for production of the whole-cell pertussis vaccine (WCV) production in Poland. Results of the study indicate that the ptxS1A-allele replaced the vaccine variant in 69% in the 1960s, and in 100% in 1990s, and although the prn1-allele was found in all strains from the 1960s and 1970s. after 1995 was gradually replaced by prn2 and prn4 variants. Presumably, vaccination could affect the population structure of B. pertussis in Poland and resulted in antigenic shift in both genes analyzed. Our findings may have implications for the composition of polish WCV and the currently licensed acellular pertussis vaccines. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:299 / 303
页数:5
相关论文
共 12 条
[1]  
Andrews R, 1997, Commun Dis Intell, V21, P145
[2]   RETURN OF EPIDEMIC PERTUSSIS IN THE UNITED-STATES [J].
BASS, JW ;
WITTLER, RR .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (05) :343-345
[3]  
BASS JW, 1997, PEDIAT INFECT DIS, V6, P141
[4]   Estimates of the effectiveness of a whole-cell pertussis vaccine from an outbreak in an immunized population [J].
BentsiEnchill, AD ;
Halperin, SA ;
Scott, J ;
MacIsaac, K ;
Duclos, P .
VACCINE, 1997, 15 (03) :301-306
[5]   The science and fiction of pertussis vaccines [J].
Cherry, JD ;
Olin, P .
PEDIATRICS, 1999, 104 (06) :1381-1384
[6]  
De Serres G., 1995, CAN COMMUN DIS REP, V15, P45
[7]   INTERACTION OF THE PERTUSSIS TOXIN PEPTIDE CONTAINING RESIDUES-30-42 WITH DR1 AND THE T-CELL RECEPTORS OF 12 HUMAN T-CELL CLONES [J].
DEMAGISTRIS, MT ;
DITOMMASO, A ;
DOMENIGHINI, M ;
CENSINI, S ;
TAGLIABUE, A ;
OKSENBERG, JR ;
STEINMAN, L ;
JUDD, AK ;
OSULLIVAN, D ;
RAPPUOLI, R .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (07) :2990-2994
[8]   Impact of anti-vaccine movements on pertussis control: the untold story [J].
Gangarosa, EJ ;
Galazka, AM ;
Wolfe, CR ;
Phillips, LM ;
Gangarosa, RE ;
Miller, E ;
Chen, RT .
LANCET, 1998, 351 (9099) :356-361
[9]   COMPARATIVE ROLES OF THE ARG-GLY-ASP SEQUENCE PRESENT IN THE BORDETELLA-PERTUSSIS ADHESINS PERTACTIN AND FILAMENTOUS HEMAGGLUTININ [J].
LEININGER, E ;
EWANOWICH, CA ;
BHARGAVA, A ;
PEPPLER, MS ;
KENIMER, JG ;
BRENNAN, MJ .
INFECTION AND IMMUNITY, 1992, 60 (06) :2380-2385
[10]   Antigenic variants in Bordetella pertussis strains isolated from vaccinated and unvaccinated children [J].
Mastrantonio, P ;
Spigaglia, P ;
van Oirschot, H ;
van der Heide, HGJ ;
Heuvelman, K ;
Stefanelli, P ;
Mooi, FR .
MICROBIOLOGY-UK, 1999, 145 :2069-2075